- About
- Membership
- Meetings & Events
- Health Policy & Advocacy
- In-Office Ancillary Services Exception (IOASE)
- Medicare Part B Drug & Physician Payment Reform
- Site Neutral Payment Reform
- Stark Law Reform
- Radiation Therapy Bundles for Cancer Treatment
- Medicare’s Local and National Coverage Determinations Guide
- Medicare Fee Schedules
- MACRA Implementation
- USPSTF Reform
- COVID-19 Advocacy Efforts
- Industry
- Residents
- Resources
- Newsroom
|
Now Enrolling, Learn How You Can Refer PatientsMany of the estimated 4 to 12 million people in the U.S. who suffer from the pain and life interruption of IC/BPS may be seeking new pain management treatments. A phase 2 clinical study will evaluate IW-3300, a novel, rectally administered foam treatment with a direct, innovative mechanism of action that may reduce pain associated with IC/BPS. Based upon phase 1 study data, IW-3300 appears to be well tolerated. Basic criteria for potential study participants include:
LEARN MORE
To see how you can get involved by referring a patient, click here to learn more.
|
Announcements
 |
|
 |
Learn how to have your facility become a SRC/NAFC Center of Excellence In Continence Care for Women. LUGPA groups will receive a discount on certification fees.
LUGPAOnsite - Can’t attend any LUGPA meetings? LUGPA experts can now deliver education to your group – in person!
LUGPA members can login to access past content On Demand.